Kryczek I - Search Results

1

LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy.

Li G, Kryczek I, Nam J, Li X, Li S, Li J, Wei S, Grove S, Vatan L, Zhou J, Du W, Lin H, Wang T, Subramanian C, Moon JJ, Cieslik M, Cohen M, Zou W. Li G, et al. Among authors: kryczek i. Nat Cell Biol. 2021 May;23(5):526-537. doi: 10.1038/s41556-021-00672-3. Epub 2021 May 6. Nat Cell Biol. 2021. PMID: 33958760 Free PMC article.

2

Regulatory T cells in ovarian cancer: biology and therapeutic potential.

Barnett B, Kryczek I, Cheng P, Zou W, Curiel TJ. Barnett B, et al. Among authors: kryczek i. Am J Reprod Immunol. 2005 Dec;54(6):369-77. doi: 10.1111/j.1600-0897.2005.00330.x. Am J Reprod Immunol. 2005. PMID: 16305662 Review.

3

Regulatory T-cell compartmentalization and trafficking.

Wei S, Kryczek I, Zou W. Wei S, et al. Among authors: kryczek i. Blood. 2006 Jul 15;108(2):426-31. doi: 10.1182/blood-2006-01-0177. Epub 2006 Mar 14. Blood. 2006. PMID: 16537800 Free PMC article. Review.

4

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma.

Kryczek I, Zou L, Rodriguez P, Zhu G, Wei S, Mottram P, Brumlik M, Cheng P, Curiel T, Myers L, Lackner A, Alvarez X, Ochoa A, Chen L, Zou W. Kryczek I, et al. J Exp Med. 2006 Apr 17;203(4):871-81. doi: 10.1084/jem.20050930. Epub 2006 Apr 10. J Exp Med. 2006. PMID: 16606666 Free PMC article.

5

Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells.

Kryczek I, Wei S, Zou L, Zhu G, Mottram P, Xu H, Chen L, Zou W. Kryczek I, et al. J Immunol. 2006 Jul 1;177(1):40-4. doi: 10.4049/jimmunol.177.1.40. J Immunol. 2006. PMID: 16785496

6

Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis.

Kryczek I, Wei S, Keller E, Liu R, Zou W. Kryczek I, et al. Am J Physiol Cell Physiol. 2007 Mar;292(3):C987-95. doi: 10.1152/ajpcell.00406.2006. Epub 2006 Aug 30. Am J Physiol Cell Physiol. 2007. PMID: 16943240 Free article. Review.

7

Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment.

Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, Chang A, Zou W. Kryczek I, et al. J Immunol. 2007 Jun 1;178(11):6730-3. doi: 10.4049/jimmunol.178.11.6730. J Immunol. 2007. PMID: 17513719

8

Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression.

Kryczek I, Wei S, Vatan L, Escara-Wilke J, Szeliga W, Keller ET, Zou W. Kryczek I, et al. J Immunol. 2007 Aug 1;179(3):1423-6. doi: 10.4049/jimmunol.179.3.1423. J Immunol. 2007. PMID: 17641006

9

Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma.

Wei S, Kryczek I, Edwards RP, Zou L, Szeliga W, Banerjee M, Cost M, Cheng P, Chang A, Redman B, Herberman RB, Zou W. Wei S, et al. Among authors: kryczek i. Cancer Res. 2007 Aug 1;67(15):7487-94. doi: 10.1158/0008-5472.CAN-07-0565. Cancer Res. 2007. PMID: 17671219 Clinical Trial.

10

Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma.

Kryczek I, Wei S, Zhu G, Myers L, Mottram P, Cheng P, Chen L, Coukos G, Zou W. Kryczek I, et al. Cancer Res. 2007 Sep 15;67(18):8900-5. doi: 10.1158/0008-5472.CAN-07-1866. Cancer Res. 2007. PMID: 17875732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters